Suchergebnisse - "d'Ettorre, Gabriella"

PubPharm (55)

1

Efficacy and tolerability of dolutegravir/lamivudine versus dolutegravir/rilpivirine in switching from a three-drug regimen based on nonnucleoside reverse transcriptase inhibitors : A retrospective cohort study

enthalten in: Journal of medical virology | 2023

von Lagi, F. | Giacomelli, A. | Borghi, V. | +12

2

Comment on : Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA study

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Ciccullo, A. | Baldin, G. | Sterrantino, G. | +4

CommentOn: J Antimicrob Chemother. 2023 Apr 3;78(4):933-945. - PMID 36775983

3

Immune Reconstitution and Safe Metabolic Profile after the Switch to Bictegravir/Emtricitabine/Tenofovir Alafenamide Fumarate among Virologically Controlled PLWH : A 96 Week Update from the BICTEL Cohort

enthalten in: Viruses | 2023

von Lazzaro, A. | Bianchini, D. | Gentilini Cacciola, E. | +10

4

The presence of resistance-associated mutations in reverse transcriptase gene is associated with cerebrospinal fluid HIV-1 escape : A multicentric retrospective analysis

enthalten in: Journal of medical virology | 2023

von Trunfio, M. | Pinnetti, C. | Arsuffi, S. | +10

5

Real-Life Impact of Drug Toxicity on Dolutegravir Tolerability : Clinical Practice Data from a Multicenter Italian Cohort

enthalten in: Viruses | 2022

von Ciccullo, A. | Baldin, G. | Borghi, V. | +13

6

Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy : Much More Than a Positive Finding

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2021

von Ciccullo, A. | Borghi, V. | Giacomelli, A. | +13

7

Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV-1-infected male patients

enthalten in: Journal of medical virology | 2021

von Santinelli, L. | De Girolamo, G. | Borrazzo, C. | +14

8

Dolutegravir-Based Regimen for Maintenance of Viral Suppression in People Living with HIV : 48-Week Results in Real-Life Setting

enthalten in: AIDS research and human retroviruses | 2021

von Di Carlo, D. | Falasca, F. | Palermo, E. | +8

9

Real word outcomes associated with use of raltegravir in older people living with HIV : results from the 60 months follow-up of the RAL-age cohort

enthalten in: Expert review of anti-infective therapy | 2020

von Santinelli, L. | Ceccarelli, G. | Borrazzo, C. | +10

10

Sex-related differences in markers of immune activation in virologically suppressed HIV-infected patients

enthalten in: Biology of sex differences | 2020

von Santinelli, L. | Ceccarelli, G. | Borrazzo, C. | +7

1
2
3
4
5
6
Nächster »
[6]